Skip to main content

Latest News

RELEASE: What Others Are Saying About the Golden State Innovation Act

Investing in Life Sciences is an Investment in CA’s Future

SACRAMENTO – At a virtual press conference, Assemblymembers Cottie Petrie-Norris, Tom Daly, Kevin Mullin and Jacqui Irwin unveiled coalition support and legislative details of the Golden State Innovation Act. Assembly Bill 593 will restore the Research and Development (R&D) Tax Credit and Net Operating Loss (NOL) deductions for Life Sciences companies in California, at a pivotal point in the state’s pandemic response and recovery.
 

RELEASE: The Golden State Innovation Act Introduced

Securing California’s Role as the Nation’s Leader in Life Sciences & Setting CA on the Road to Recovery

SACRAMENTO – The Golden State Innovation Act of 2021 (AB 593) has been introduced to fuel job growth and innovation through the restoration of the Research and Development (R&D) Tax Credit and Net Operating Loss (NOL) deduction for Life Sciences companies in California.  AB 593 was introduced by Assemblymembers Cottie Petrie-Norris, Kevin Mullin, Tom Daly and Jacqui Irwin and is supported by a coalition of Life Science companies and patient-advocacy groups.

RELEASE: Legislation Introduced to Increase Access to Senior Services

AB 540 Will Help Seniors Remain in Their Homes

SACRAMENTO — Assemblywoman Petrie-Norris has introduced Assembly Bill 540 which will help thousands of California’s growing population of seniors remain in their homes and in our communities, by improving beneficiary awareness and access to the Program of All-Inclusive Care for the Elderly (PACE).
 

RELEASE: Oversight Hearing Brings Clarity to California’s COVID-19 Vaccine Distribution

Administration Updated Legislature & the Public on New Rollout Plans

SACRAMENTO – At a joint oversight hearing February 10, 2021 of the Assembly Accountability and Administrative Review Committee and the Assembly Emergency Management Committee, legislators questioned the Administration on the COVID-19 vaccine distribution strategy. During the hearing, the Administration shared details on their shorterm and longterm plans for a successful and equitable rollout of the vaccine in California. Additionally, there was an update on vaccine distribution data, the MyTurn Appointment system and supply estimates for the upcoming months.